IL-17 Cytokines and Chronic Lung Diseases
- PMID: 35883573
- PMCID: PMC9318387
- DOI: 10.3390/cells11142132
IL-17 Cytokines and Chronic Lung Diseases
Abstract
IL-17 cytokines are expressed by numerous cells (e.g., gamma delta (γδ) T, innate lymphoid (ILC), Th17, epithelial cells). They contribute to the elimination of bacteria through the induction of cytokines and chemokines which mediate the recruitment of inflammatory cells to the site of infection. However, IL-17-driven inflammation also likely promotes the progression of chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, and asthma. In this review, we highlight the role of IL-17 cytokines in chronic lung diseases.
Keywords: IL-17; infection; inflammation; lung damage; lung diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures



References
-
- Chen K., Eddens T., Trevejo-Nunez G., Way E.E., Elsegeiny W., Ricks D.M., Garg A.V., Erb C.J., Bo M., Wang T., et al. IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae. Cell Host Microbe. 2016;20:596–605. doi: 10.1016/j.chom.2016.10.003. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical